ArticleThe Journal of clinical endocrinology and metabolism2019

Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.

Michael Mannstadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.